By the Top Tier Newswire AI Desk · August 27, 2026 at 12:17 AM ET · reviewed against 1 wire stories
NANOBIOTIX S A ADR (NBTX) is up +7.20% in the latest session. Our newswire has captured 1 story on NBTX across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 50/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
NBTX stock is up 7.20% at $44.50 as of the latest market data. The move follows a corporate update on the company’s share capital and voting rights, as well as continued positive momentum in its clinical and financial developments. The stock is trading near its 52-week high, reflecting renewed investor interest.
What Happened
Nanobiotix announced an update to its share capital and voting rights as of July 31, 2026, disclosing 50,833,462 shares outstanding and 54,534,179 theoretical voting rights. The company has been in the news for its progress in the JNJ-1900 NSCLC Phase 2 study, which reported an 85.7% response rate in the first quarter of 2026. In addition, the FDA accepted the NANORAY-312 protocol amendment, signaling regulatory progress. Leerink Partners recently raised its price target for Nanobiotix to $46 and maintained its Outperform rating. The company also launched a global follow-on offering of approximately €75 million to advance its Nanoprimer platform.
What The Data Shows
NBTX printed 13 fresh 52-week highs on August 27, 2026, as the stock approached its 52-week high of $57.14. The stock has a market cap of $2.0 billion and a beta of 0.57, indicating lower volatility than the broader market. Despite a trailing twelve-month revenue decline of 553.2% and a net margin of -73.5%, the recent clinical and financing developments have driven investor optimism.
What To Watch
Nanobiotix has no scheduled earnings report in the near term. Investors should monitor coverage breadth and any further updates from clinical trials or financing activities.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
NBTX · Aug 27 session (5-min) · +2.25% vs prior close · updated 8:48 PM ETAI sentiment, last 36h · averaged over 1 story · 50/100 neutral
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
18d agoTipRanksNEUTRAL 50General
Nanobiotix Updates Share Capital and Voting Rights as of July 31, 2026
Nanobiotix ( ($FR:NANO) ) just unveiled an announcement. Nanobiotix reported that as of July 31, 2026, it had 50,833,462 shares outstanding and 54,534,179 theoretic...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →